A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Clinical trial NCT05732454 · TERMINATED

Trial details

NCT number: NCT05732454
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis Atopic Dermatitis, Unspecified Eczema Eczema, Atopic

Start date: 2023-01-18
Primary completion: 2024-04-29
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.